Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
Episode 31 and 33 have been developed by EPG Health for Medthority in collaboration with J. Uriach y Compañía S.A.
All opinions expressed in the ‘All Things Urticaria’ podcast series are those of Professor Marcus Maurer and his guests. This content should not be taken as medical advice and is for informational purposes only. Please consult your regional clinical practice guidelines for clinical practice recommendations in your area.